Patents by Inventor Jennica Krankel

Jennica Krankel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200079880
    Abstract: The present invention provides compositions useful as prodrugs and methods for making the same. The compositions include a fusion protein having a first delivery domain and a second protein precursor domain linked together via a linker sequence. The delivery domain is a protein capable of facilitating entry to target cells via the endocytotic pathway, such as transferrin. The protein precursor is a prohormone or a profactor, such as proinsulin. Methods of this invention include the steps of selecting a protein suitable as the delivery domain, constructing a vector to encode the fusion protein, and expressing the fusion protein in a suitable expression host. Also disclosed is a method for targeted delivery of prodrugs to livers and a method of reducing hepatic glucose production.
    Type: Application
    Filed: November 13, 2019
    Publication date: March 12, 2020
    Inventors: Wei-Chiang Shen, Yan Wang, Jennica Krankel
  • Patent number: 10513563
    Abstract: The present invention provides compositions useful as prodrugs and methods for making the same. The compositions include a fusion protein having a first delivery domain and a second protein precursor domain linked together via a linker sequence. The delivery domain is a protein capable of facilitating entry to a target cells via the endocytotic pathway, such as transferrin. The protein precursor is a prohormone or a profactor, such as proinsulin. Methods of this invention include the steps of selecting a protein suitable as the delivery domain, constructing a vector to encode the fusion protein, and expressing the fusion protein in a suitable expression host. Also disclosed is a method for targeted-delivery of prodrugs to livers and a method of reducing hepatic glucose production.
    Type: Grant
    Filed: May 21, 2012
    Date of Patent: December 24, 2019
    Assignee: University of Southern California
    Inventors: Wei-Chiang Shen, Yan Wang, Jennica Krankel
  • Publication number: 20190022240
    Abstract: The present invention discloses a design for a molecular delivery vehicle capable of delivering a molecular payload to a target cell and its intracellular compartments. Also disclosed are highly pH-sensitive nanoconstruct that takes advantage of the requirement of cationic charge for internalization of CPPs to mask the non-specific internalization, compositions containing nanoconstruct, and methods for forming the same.
    Type: Application
    Filed: October 4, 2018
    Publication date: January 24, 2019
    Inventors: Wei-Chiang SHEN, Jennica KRANKEL, Likun FEI
  • Publication number: 20140206596
    Abstract: The present invention discloses a design for a molecular delivery vehicle capable of delivering a molecular payload to a target cell and its intracellular compartments. Also disclosed are highly pH-sensitive nanoconstruct that takes advantage of the requirement of cationic charge for internalization of CPPs to mask the non-specific internalization, compositions containing nanoconstruct, and methods for forming the same.
    Type: Application
    Filed: January 16, 2014
    Publication date: July 24, 2014
    Applicant: University of Southern California
    Inventors: Wei-Chiang SHEN, Jennica KRANKEL, Likun FEI
  • Publication number: 20130130967
    Abstract: The present invention provides compositions useful as prodrugs and methods for making the same. The compositions include a fusion protein having a first delivery domain and a second protein precursor domain linked together via a linker sequence. The delivery domain is a protein capable of facilitating entry to a target cells via the endocytotic pathway, such as transferrin. The protein precursor is a prohormone or a profactor, such as proinsulin. Methods of this invention include the steps of selecting a protein suitable as the delivery domain, constructing a vector to encode the fusion protein, and expressing the fusion protein in a suitable expression host. Also disclosed is a method for targeted-delivery of prodrugs to livers and a method of reducing hepatic glucose production.
    Type: Application
    Filed: May 21, 2012
    Publication date: May 23, 2013
    Applicant: UNIVERSITY OF SOUTHERN CALIFORNIA
    Inventors: Wei-Chiang SHEN, Yan WANG, Jennica Krankel